866-997-4948(US-Canada Toll Free)

Global RNA-Based Vaccines Market Insights, Forecast to 2025

Published By :

QYResearch

Published Date : Sep 2018

Category :

Pharmaceutical

No. of Pages : 107 Pages

This report studies the global market size of RNA-Based Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of RNA-Based Vaccines in these regions.
This research report categorizes the global RNA-Based Vaccines market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

In 2017, the global RNA-Based Vaccines market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the RNA-Based Vaccines market based on company, product type, application and key regions.

The various contributors involved in the value chain of RNA-Based Vaccines include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the RNA-Based Vaccines include
Pfizer
Roche
Sanofi-Aventis
Abbott Laboratories
Arrowhead Pharmaceuticals
Benitec Biopharma
Calimmune Inc
Dicerna
Gradalis
Quark
RXi
Senesco
Silence Therapeutics
Silenseed
Tekmira
Alnylam Pharmaceuticals

Market Size Split by Type
Type I
Type II
Market Size Split by Application
Cancer
Diabetes
Tuberculosis
Cardiovascular Diseases
Others

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global RNA-Based Vaccines market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of RNA-Based Vaccines market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global RNA-Based Vaccines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the RNA-Based Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of RNA-Based Vaccines submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of RNA-Based Vaccines are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of RNA-Based Vaccines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
1.1 RNA-Based Vaccines Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global RNA-Based Vaccines Market Size Growth Rate by Type
1.4.2 Type I
1.4.3 Type II
1.5 Market by Application
1.5.1 Global RNA-Based Vaccines Market Size Growth Rate by Application
1.5.2 Cancer
1.5.3 Diabetes
1.5.4 Tuberculosis
1.5.5 Cardiovascular Diseases
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global RNA-Based Vaccines Market Size
2.1.1 Global RNA-Based Vaccines Revenue 2016-2025
2.1.2 Global RNA-Based Vaccines Sales 2016-2025
2.2 RNA-Based Vaccines Growth Rate by Regions
2.2.1 Global RNA-Based Vaccines Sales by Regions
2.2.2 Global RNA-Based Vaccines Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 RNA-Based Vaccines Sales by Manufacturers
3.1.1 RNA-Based Vaccines Sales by Manufacturers
3.1.2 RNA-Based Vaccines Sales Market Share by Manufacturers
3.1.3 Global RNA-Based Vaccines Market Concentration Ratio (CR5 and HHI)
3.2 RNA-Based Vaccines Revenue by Manufacturers
3.2.1 RNA-Based Vaccines Revenue by Manufacturers (2016-2018)
3.2.2 RNA-Based Vaccines Revenue Share by Manufacturers (2016-2018)
3.3 RNA-Based Vaccines Price by Manufacturers
3.4 RNA-Based Vaccines Manufacturing Base Distribution, Product Types
3.4.1 RNA-Based Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers RNA-Based Vaccines Product Category
3.4.3 Date of International Manufacturers Enter into RNA-Based Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global RNA-Based Vaccines Sales by Type
4.2 Global RNA-Based Vaccines Revenue by Type
4.3 RNA-Based Vaccines Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global RNA-Based Vaccines Breakdown Data by Application

6 North America
6.1 North America RNA-Based Vaccines by Countries
6.1.1 North America RNA-Based Vaccines Sales by Countries
6.1.2 North America RNA-Based Vaccines Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America RNA-Based Vaccines by Type
6.3 North America RNA-Based Vaccines by Application
6.4 North America RNA-Based Vaccines by Company

7 Europe
7.1 Europe RNA-Based Vaccines by Countries
7.1.1 Europe RNA-Based Vaccines Sales by Countries
7.1.2 Europe RNA-Based Vaccines Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe RNA-Based Vaccines by Type
7.3 Europe RNA-Based Vaccines by Application
7.4 Europe RNA-Based Vaccines by Company

8 Asia Pacific
8.1 Asia Pacific RNA-Based Vaccines by Countries
8.1.1 Asia Pacific RNA-Based Vaccines Sales by Countries
8.1.2 Asia Pacific RNA-Based Vaccines Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific RNA-Based Vaccines by Type
8.3 Asia Pacific RNA-Based Vaccines by Application
8.4 Asia Pacific RNA-Based Vaccines by Company

9 Central & South America
9.1 Central & South America RNA-Based Vaccines by Countries
9.1.1 Central & South America RNA-Based Vaccines Sales by Countries
9.1.2 Central & South America RNA-Based Vaccines Revenue by Countries
9.1.3 Brazil
9.2 Central & South America RNA-Based Vaccines by Type
9.3 Central & South America RNA-Based Vaccines by Application
9.4 Central & South America RNA-Based Vaccines by Company

10 Middle East and Africa
10.1 Middle East and Africa RNA-Based Vaccines by Countries
10.1.1 Middle East and Africa RNA-Based Vaccines Sales by Countries
10.1.2 Middle East and Africa RNA-Based Vaccines Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa RNA-Based Vaccines by Type
10.3 Middle East and Africa RNA-Based Vaccines by Application
10.4 Middle East and Africa RNA-Based Vaccines by Company

11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of RNA-Based Vaccines
11.1.4 RNA-Based Vaccines Product Description
11.1.5 Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of RNA-Based Vaccines
11.2.4 RNA-Based Vaccines Product Description
11.2.5 Recent Development
11.3 Sanofi-Aventis
11.3.1 Sanofi-Aventis Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of RNA-Based Vaccines
11.3.4 RNA-Based Vaccines Product Description
11.3.5 Recent Development
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of RNA-Based Vaccines
11.4.4 RNA-Based Vaccines Product Description
11.4.5 Recent Development
11.5 Arrowhead Pharmaceuticals
11.5.1 Arrowhead Pharmaceuticals Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of RNA-Based Vaccines
11.5.4 RNA-Based Vaccines Product Description
11.5.5 Recent Development
11.6 Benitec Biopharma
11.6.1 Benitec Biopharma Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of RNA-Based Vaccines
11.6.4 RNA-Based Vaccines Product Description
11.6.5 Recent Development
11.7 Calimmune Inc
11.7.1 Calimmune Inc Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of RNA-Based Vaccines
11.7.4 RNA-Based Vaccines Product Description
11.7.5 Recent Development
11.8 Dicerna
11.8.1 Dicerna Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of RNA-Based Vaccines
11.8.4 RNA-Based Vaccines Product Description
11.8.5 Recent Development
11.9 Gradalis
11.9.1 Gradalis Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of RNA-Based Vaccines
11.9.4 RNA-Based Vaccines Product Description
11.9.5 Recent Development
11.10 Quark
11.10.1 Quark Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of RNA-Based Vaccines
11.10.4 RNA-Based Vaccines Product Description
11.10.5 Recent Development
11.11 RXi
11.12 Senesco
11.13 Silence Therapeutics
11.14 Silenseed
11.15 Tekmira
11.16 Alnylam Pharmaceuticals

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key RNA-Based Vaccines Raw Material
13.1.2 RNA-Based Vaccines Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Table

List of Tables and Figures

Figure Picture of RNA-Based Vaccines
Figure Global RNA-Based Vaccines Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global RNA-Based Vaccines Production Market Share by Types (Product Category) in 2017
Figure Type I Product Picture
Table Major Manufacturers of Type I
Figure Type II Product Picture
Table Major Manufacturers of Type II
Table Global RNA-Based Vaccines Market Size Growth Rate by Application 2018-2025 (K Units)
Figure Cancer
Figure Diabetes
Figure Tuberculosis
Figure Cardiovascular Diseases
Figure Others
Figure RNA-Based Vaccines Report Years Considered
Figure Global RNA-Based Vaccines Market Size 2016-2025 (Million US$)
Figure Global RNA-Based Vaccines Sales 2016-2025 (K Units)
Table Global RNA-Based Vaccines Market Size by Regions 2016-2025 (K Units) & (Million US$)
Table Global RNA-Based Vaccines Sales by Regions 2016-2025 (K Units)
Table Global RNA-Based Vaccines Sales Market Share by Regions 2016-2025
Figure Global RNA-Based Vaccines Sales Market Share by Regions 2016-2025
Figure 2017 Global RNA-Based Vaccines Sales Market Share by Regions
Table Global RNA-Based Vaccines Revenue by Regions 2016-2025 (Million US$)
Table Global RNA-Based Vaccines Revenue Market Share by Regions 2016-2025
Figure Global RNA-Based Vaccines Revenue Market Share by Regions 2016-2025
Figure 2017 Global RNA-Based Vaccines Revenue Market Share by Regions
Table Global RNA-Based Vaccines Sales by Manufacturers (2016-2018) (K Units)
Table Global RNA-Based Vaccines Sales Share by Manufacturers (2016-2018)
Figure Global RNA-Based Vaccines Sales Share by Manufacturers in 2017
Table RNA-Based Vaccines Revenue by Manufacturers (2016-2018) (Million US$)
Table RNA-Based Vaccines Revenue Share by Manufacturers (2016-2018)
Figure RNA-Based Vaccines Value Share by Manufacturers in 2017
Table Global RNA-Based Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers RNA-Based Vaccines Price (2016-2018) (USD/Unit)
Table RNA-Based Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers RNA-Based Vaccines Product Category
Table Date of International Manufacturers Enter into RNA-Based Vaccines Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global RNA-Based Vaccines Sales by Type (2016-2025) (K Units)
Table Global RNA-Based Vaccines Sales Share by Type (2016-2025)
Figure Global RNA-Based Vaccines Sales Market Share by Type (2016-2025)
Figure Global RNA-Based Vaccines Sales Market Share by Type in 2017
Table Global RNA-Based Vaccines Revenue by Type (2016-2025) (Million US$)
Table Global RNA-Based Vaccines Revenue Share by Type (2016-2025)
Figure Global RNA-Based Vaccines Revenue Market Share by Type (2016-2025)
Figure Global RNA-Based Vaccines Revenue Market Share by Type in 2017
Table RNA-Based Vaccines Price by Type 2013-2018 (USD/Unit)
Table Global RNA-Based Vaccines Sales by Application (2016-2025) (K Units)
Table Global RNA-Based Vaccines Sales Share by Application (2016-2025)
Figure Global Sales RNA-Based Vaccines Market Share by Application (2016-2025)
Figure Global Sales RNA-Based Vaccines Market Share by Application (2016-2025)
Figure North America RNA-Based Vaccines Sales Growth Rate 2016-2025 (K Units)
Figure North America RNA-Based Vaccines Revenue Growth Rate 2016-2025 (Million US$)
Table North America RNA-Based Vaccines Sales by Countries (2016-2025) (K Units)
Table North America RNA-Based Vaccines Sales Market Share by Countries (2016-2025)
Figure 2017 North America RNA-Based Vaccines Sales Market Share by Countries
Table North America RNA-Based Vaccines Revenue by Countries (2016-2025) (Million US$)
Table North America RNA-Based Vaccines Revenue Market Share by Countries (2016-2025)
Figure 2017 North America RNA-Based Vaccines Revenue Market Share by Countries
Figure United States RNA-Based Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure United States RNA-Based Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada RNA-Based Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Canada RNA-Based Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico RNA-Based Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Mexico RNA-Based Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Table North America RNA-Based Vaccines Sales by Type (2016-2025) (K Units)
Table North America RNA-Based Vaccines Sales Market Share by Type (2016-2025)
Figure 2017 North America RNA-Based Vaccines Market Share by Type
Table North America RNA-Based Vaccines Sales by Application (2016-2025) (K Units)
Table North America RNA-Based Vaccines Sales Market Share by Application (2016-2025)
Figure 2017 North America RNA-Based Vaccines Market Share by Application
Table North America RNA-Based Vaccines Sales by Company (2016-2018) (K Units)
Table North America RNA-Based Vaccines Sales Market Share by Company (2016-2018)
Figure North America RNA-Based Vaccines Sales Market Share by Company in 2017
Figure Europe RNA-Based Vaccines Sales Growth Rate 2016-2025 (K Units)
Figure Europe RNA-Based Vaccines Revenue Growth Rate 2016-2025 (Million US$)
Table Europe RNA-Based Vaccines Sales by Countries (2016-2025) (K Units)
Table Europe RNA-Based Vaccines Sales Market Share by Countries (2016-2025)
Figure 2017 Europe RNA-Based Vaccines Sales Market Share by Countries
Table Europe RNA-Based Vaccines Revenue by Countries (2016-2025) (Million US$)
Table Europe RNA-Based Vaccines Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe RNA-Based Vaccines Revenue Market Share by Countries
Figure Germany RNA-Based Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Germany RNA-Based Vaccines Revenue Growth Rate (2016-2025) (K Units)
Figure France RNA-Based Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure France RNA-Based Vaccines Revenue Growth Rate (2016-2025) (K Units)
Figure UK RNA-Based Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure UK RNA-Based Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy RNA-Based Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Italy RNA-Based Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia RNA-Based Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Russia RNA-Based Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Table Europe RNA-Based Vaccines Sales by Type (2016-2025) (K Units)
Table Europe RNA-Based Vaccines Sales Market Share by Type (2016-2025)
Figure 2017 Europe RNA-Based Vaccines Market Share by Type
Table Europe RNA-Based Vaccines Sales by Application (2016-2025) (K Units)
Table Europe RNA-Based Vaccines Sales Market Share by Application (2016-2025)
Figure 2017 Europe RNA-Based Vaccines Market Share by Application
Table Europe RNA-Based Vaccines Sales by Company (2016-2018) (K Units)
Table Europe RNA-Based Vaccines Sales Market Share by Company (2016-2018)
Figure Europe RNA-Based Vaccines Sales Market Share by Company in 2017
Figure Asia Pacific RNA-Based Vaccines Sales Growth Rate 2016-2025 (K Units)
Figure Asia Pacific RNA-Based Vaccines Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific RNA-Based Vaccines Sales by Countries (2016-2025) (K Units)
Table Asia Pacific RNA-Based Vaccines Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific RNA-Based Vaccines Sales Market Share by Countries
Table Asia Pacific RNA-Based Vaccines Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific RNA-Based Vaccines Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific RNA-Based Vaccines Revenue Market Share by Countries
Figure China RNA-Based Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure China RNA-Based Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan RNA-Based Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Japan RNA-Based Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea RNA-Based Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Korea RNA-Based Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure India RNA-Based Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure India RNA-Based Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia RNA-Based Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Australia RNA-Based Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia RNA-Based Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Indonesia RNA-Based Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia RNA-Based Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Malaysia RNA-Based Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines RNA-Based Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Philippines RNA-Based Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand RNA-Based Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Thailand RNA-Based Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam RNA-Based Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Vietnam RNA-Based Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore RNA-Based Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Singapore RNA-Based Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific RNA-Based Vaccines Sales by Type (2016-2025) (K Units)
Table Asia Pacific RNA-Based Vaccines Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific RNA-Based Vaccines Market Share by Type
Table Asia Pacific RNA-Based Vaccines Sales by Application (2016-2025) (K Units)
Table Asia Pacific RNA-Based Vaccines Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific RNA-Based Vaccines Market Share by Application
Table Asia Pacific RNA-Based Vaccines Sales by Company (2016-2018) (K Units)
Table Asia Pacific RNA-Based Vaccines Sales Market Share by Company (2016-2018)
Figure Asia Pacific RNA-Based Vaccines Sales Market Share by Company in 2017
Figure Central & South America RNA-Based Vaccines Sales Growth Rate 2016-2025 (K Units)
Figure Central & South America RNA-Based Vaccines Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America RNA-Based Vaccines Sales by Countries (2016-2025) (K Units)
Table Central & South America RNA-Based Vaccines Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America RNA-Based Vaccines Sales Market Share by Countries
Table Central & South America RNA-Based Vaccines Revenue by Countries (2016-2025) (Million US$)
Table Central & South America RNA-Based Vaccines Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America RNA-Based Vaccines Revenue Market Share by Countries
Figure Brazil RNA-Based Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Brazil RNA-Based Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina RNA-Based Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Argentina RNA-Based Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America RNA-Based Vaccines Sales by Type (2016-2025) (K Units)
Table Central & South America RNA-Based Vaccines Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America RNA-Based Vaccines Market Share by Type
Table Central & South America RNA-Based Vaccines Sales by Application (2016-2025) (K Units)
Table Central & South America RNA-Based Vaccines Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America RNA-Based Vaccines Market Share by Application
Table Central & South America RNA-Based Vaccines Sales by Company (2016-2018) (K Units)
Table Central & South America RNA-Based Vaccines Sales Market Share by Company (2016-2018)
Figure Central & South America RNA-Based Vaccines Sales Market Share by Company in 2017
Figure Middle East and Africa RNA-Based Vaccines Sales Growth Rate 2016-2025 (K Units)
Figure Middle East and Africa RNA-Based Vaccines Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa RNA-Based Vaccines Sales by Countries (2016-2025) (K Units)
Table Middle East and Africa RNA-Based Vaccines Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa RNA-Based Vaccines Sales Market Share by Countries
Table Middle East and Africa RNA-Based Vaccines Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa RNA-Based Vaccines Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa RNA-Based Vaccines Revenue Market Share by Countries
Figure GCC Countries RNA-Based Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure GCC Countries RNA-Based Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey RNA-Based Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Turkey RNA-Based Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt RNA-Based Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Egypt RNA-Based Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa RNA-Based Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure South Africa RNA-Based Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa RNA-Based Vaccines Sales by Type (2016-2025) (K Units)
Table Middle East and Africa RNA-Based Vaccines Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa RNA-Based Vaccines Market Share by Type
Table Middle East and Africa RNA-Based Vaccines Sales by Application (2016-2025) (K Units)
Table Middle East and Africa RNA-Based Vaccines Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa RNA-Based Vaccines Market Share by Application
Table Middle East and Africa RNA-Based Vaccines Sales by Company (2016-2018) (K Units)
Table Middle East and Africa RNA-Based Vaccines Sales Market Share by Company (2016-2018)
Figure Middle East and Africa RNA-Based Vaccines Sales Market Share by Company in 2017
Table Pfizer Company Details
Table Pfizer RNA-Based Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Pfizer Recent Development
Table Roche Company Details
Table Roche RNA-Based Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Roche Recent Development
Table Sanofi-Aventis Company Details
Table Sanofi-Aventis RNA-Based Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Sanofi-Aventis Recent Development
Table Abbott Laboratories Company Details
Table Abbott Laboratories RNA-Based Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Abbott Laboratories Recent Development
Table Arrowhead Pharmaceuticals Company Details
Table Arrowhead Pharmaceuticals RNA-Based Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Arrowhead Pharmaceuticals Recent Development
Table Benitec Biopharma Company Details
Table Benitec Biopharma RNA-Based Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Benitec Biopharma Recent Development
Table Calimmune Inc Company Details
Table Calimmune Inc RNA-Based Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Calimmune Inc Recent Development
Table Dicerna Company Details
Table Dicerna RNA-Based Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Dicerna Recent Development
Table Gradalis Company Details
Table Gradalis RNA-Based Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Gradalis Recent Development
Table Quark Company Details
Table Quark RNA-Based Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Quark Recent Development
Table RXi Company Details
Table Senesco Company Details
Table Silence Therapeutics Company Details
Table Silenseed Company Details
Table Tekmira Company Details
Table Alnylam Pharmaceuticals Company Details
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table RNA-Based Vaccines Value Chain
Table Typical Suppliers of Key RNA-Based Vaccines Raw Material
Table RNA-Based Vaccines Customers List
Table RNA-Based Vaccines Sales Channels
Table RNA-Based Vaccines Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *